Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
AI therapy planning support assistant launched by deepeye Medical receives CE mark
Published on May 28, 2025
deepeye TPS is designed to close the gap between real-world outcomes and trial data by reducing patient dropout.
Continue reading on website
Other news
Driving in the Dark: Fuchs’ Patients Have Reduced Nighttime Vision Despite Normal VA
May 28, 2025
Using the National Advanced Driving Simulator, a small study showed that patients with Fuchs’ dystrophy had shorter hazard detection distances under glare conditions (i.e., headlights) than controls without the disease. Photo: Christine Sindt, OD. Click image to enlarge. As one of the many daily activities affected by Fuchs’ endothelial corneal dystrophy (FECD), patients may
ARVO 2025: Miebo demonstrates favorable tolerability in prescription refill rates
May 28, 2025
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, details the key takeaways from a poster presentation she participated in during ARVO 2025.
